MedTrace Logo

Thrombus Aspiration in Heavy Thrombus Burden Acute ST-elevation Myocardial Infarction

NCT04912570 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2023-07-14

No results posted yet for this study

Summary

Recent guidelines for the management of ST-elevation myocardial infarction (STEMI) recommend against the routine use of thrombus aspiration (TA) during primary percutaneous coronary intervention (PPCI) (Class III indication). Yet, so far, there is limited data regarding its role STEMI patients with heavy thrombus burden (TB).

The aim of this trial is to evaluate the effects of manual TA and PCI in comparison to conventional PCI alone in a real-life clinical trial among heavy TB STEMI patients undergoing PPCI.

Conditions

Interventions

PROCEDURE

Manual Thrombus Aspiration

Manual thrombus aspiration using one of the FDA approved aspirators will be done.

PROCEDURE

Standard PCI

Standard PCI according to the most recent guidelines

Sponsors & Collaborators

  • The Young Investigator Group of Cardiovascular Research

    lead NETWORK

Principal Investigators

  • Haitham Badran, MD · Ain Shams University - Egypt

  • Mahmoud H Abdelnabi, MD · University of Alexandria - Egypt

  • Ahmed M El Amrawy, MD · University of Alexandria - Egypt

  • Yasser Sadek, MD · National Heart Institute, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2024-07-01
Completion
2024-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04912570 on ClinicalTrials.gov